BSE Live
Dec 18, 16:01Prev. Close
1272.00
Open Price
1271.00
Bid Price (Qty.)
1275.00 (2)
Offer Price (Qty.)
1279.60 (27)
NSE Live
Dec 18, 15:58Prev. Close
1272.00
Open Price
1277.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
1280.00 (338)
| Balance Sheet of Dr Reddys Laboratories (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 83.10 | 83.00 | 83.00 | 82.90 | 85.30 | |
| Total Share Capital | 83.10 | 83.00 | 83.00 | 82.90 | 85.30 | |
| Reserves and Surplus | 15,515.70 | 13,940.60 | 12,488.60 | 12,179.20 | 12,484.50 | |
| Total Reserves and Surplus | 15,515.70 | 13,940.60 | 12,488.60 | 12,179.20 | 12,484.50 | |
| Total Shareholders Funds | 15,598.80 | 14,023.60 | 12,571.60 | 12,262.10 | 12,569.80 | |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 130.40 | 2,200.00 | 2,508.90 | 544.90 | 1,068.50 | |
| Deferred Tax Liabilities [Net] | 2.00 | 47.30 | 195.00 | 162.00 | 53.70 | |
| Other Long Term Liabilities | 205.50 | 218.10 | 293.30 | 343.40 | 250.30 | |
| Long Term Provisions | 74.50 | 79.30 | 81.70 | 84.20 | 94.70 | |
| Total Non-Current Liabilities | 412.40 | 2,544.70 | 3,078.90 | 1,134.50 | 1,467.20 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 1,653.20 | 1,212.50 | 2,556.20 | 4,362.60 | 2,271.80 | |
| Trade Payables | 1,524.80 | 1,367.10 | 1,334.50 | 1,056.90 | 906.80 | |
| Other Current Liabilities | 3,569.20 | 2,838.80 | 2,564.40 | 2,487.90 | 2,639.50 | |
| Short Term Provisions | 466.90 | 478.90 | 438.70 | 512.50 | 529.00 | |
| Total Current Liabilities | 7,214.10 | 5,897.30 | 6,893.80 | 8,419.90 | 6,347.10 | |
| Total Capital And Liabilities | 23,225.30 | 22,465.60 | 22,544.30 | 21,816.50 | 20,384.10 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 4,777.90 | 4,912.70 | 4,973.30 | 5,028.10 | 4,613.00 | |
| Intangible Assets | 1,581.10 | 1,812.40 | 1,461.60 | 1,426.30 | 1,485.00 | |
| Capital Work-In-Progress | 436.40 | 472.50 | 767.80 | 609.50 | 662.60 | |
| Fixed Assets | 7,894.10 | 9,658.60 | 9,905.40 | 9,778.90 | 6,870.20 | |
| Non-Current Investments | 309.10 | 334.20 | 465.30 | 682.60 | 329.70 | |
| Deferred Tax Assets [Net] | 1,219.90 | 431.70 | 540.50 | 678.40 | 590.50 | |
| Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Non-Current Assets | 711.80 | 465.10 | 601.60 | 516.60 | 334.70 | |
| Total Non-Current Assets | 10,626.20 | 11,355.50 | 12,045.90 | 12,132.80 | 8,590.10 | |
| CURRENT ASSETS | ||||||
| Current Investments | 2,368.70 | 2,252.90 | 1,833.00 | 1,427.10 | 3,503.40 | |
| Inventories | 3,506.70 | 3,357.90 | 2,908.90 | 2,852.80 | 2,557.90 | |
| Trade Receivables | 5,027.80 | 3,986.90 | 4,052.70 | 3,798.60 | 4,125.00 | |
| Cash And Cash Equivalents | 205.30 | 222.80 | 263.80 | 386.50 | 492.10 | |
| Short Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| OtherCurrentAssets | 1,490.60 | 1,289.60 | 1,440.00 | 1,218.70 | 1,115.60 | |
| Total Current Assets | 12,599.10 | 11,110.10 | 10,498.40 | 9,683.70 | 11,794.00 | |
| Total Assets | 23,225.30 | 22,465.60 | 22,544.30 | 21,816.50 | 20,384.10 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 1,040.60 | 577.90 | 871.10 | 1,017.90 | 571.50 | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 55.87 | 55.87 | 55.87 | 55.87 | 55.87 | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | 30.30 | 79.10 | 119.40 | 496.20 | 174.70 | |
| Non-Current Investments Unquoted Book Value | 2,371.20 | 2,255.10 | 631.80 | 26.10 | 3,527.30 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Current Investments Unquoted Book Value | 0.00 | 0.00 | 1,336.70 | 1,427.10 | 0.00 |
15.12.2025
12.12.2025
25.11.2025
11.11.2025
28.10.2025
Dr Reddys Labs Consolidated September 2025 Net Sales at Rs 8,828.30 crore, up 9.83% Y-o-Y
28.10.2025
Dr Reddys Labs Standalone September 2025 Net Sales at Rs 4,618.60 crore, down 31.03% Y-o-Y
24.10.2025
Dr Reddy's Q2 Results: Net profit rises 7% to Rs 1,347 crore, misses estimates
24.07.2025
Dr Reddys Labs Standalone June 2025 Net Sales at Rs 7,809.50 crore, up 33.7% Y-o-Y
22.01.2025
Dr Reddy's Labs Q3 Preview: Lower Revlimid contribution, subdued US sales to dent earnings growth
12.07.2023
Dr Reddys Laboratories Q1 PAT seen up 73.7% YoY to Rs 912.4 cr: Nirmal Bang
24.01.2023
Dr Reddy’s Q3 Preview | Sharp drop in net profit likely on slump in US revenues
27.10.2022
Dr Reddy’s Q2 preview: Pharma major likely to report sharp drop in net profit on weak US biz